Complete the nine sections; the result classification is computed on submit. This is a classification form — there is no numeric score.
Who took the sample, in what role and setting, and when.
Local identifier, NHS number, age, and date of birth. Age drives eligibility.
Routine screening applies to ages 25-64. An age outside the range ceases the screen.
Recall interval, screen-due date, and whether the person is overdue or has formally ceased screening. A ceased record ends the pathway with no recall.
Informed consent to take the sample and process the result. A result must not be reported without recorded consent.
Abnormal bleeding, discharge, or pain. A symptomatic person is managed on the symptomatic (NICE NG12) pathway irrespective of the screening result — a negative screen does not exclude cancer.
An inadequate sample is never HPV-classified; it is repeated in ~3 months (three consecutive inadequate samples escalate to colposcopy).
The primary high-risk HPV test. A negative result returns the person to routine recall; only a positive result proceeds to reflex cytology.
Reflex cytology is performed only on an hrHPV-positive sample. It refines a positive result into normal (12-month repeat), low-grade abnormal (routine colposcopy), or high-grade abnormal (urgent colposcopy).
Reflex cytology does not apply: the primary hrHPV result is not positive. Record a positive hrHPV result in the previous step to grade reflex cytology.
Live result classification and management action, plus a free-text clinical note. Submit to generate the full report.